Aerie Pharmaceuticals Inc
NASDAQ:AERI
Aerie Pharmaceuticals Inc
Cash from Investing Activities
Aerie Pharmaceuticals Inc
Cash from Investing Activities Peer Comparison
Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Investing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Aerie Pharmaceuticals Inc
NASDAQ:AERI
|
Cash from Investing Activities
-$18.3m
|
CAGR 3-Years
44%
|
CAGR 5-Years
20%
|
CAGR 10-Years
N/A
|
|
Johnson & Johnson
NYSE:JNJ
|
Cash from Investing Activities
$878m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Cash from Investing Activities
-$21.7B
|
CAGR 3-Years
-23%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Pfizer Inc
NYSE:PFE
|
Cash from Investing Activities
-$32.3B
|
CAGR 3-Years
-96%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-12%
|
|
Merck & Co Inc
NYSE:MRK
|
Cash from Investing Activities
-$14.1B
|
CAGR 3-Years
-18%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-9%
|
|
Eli Lilly and Co
NYSE:LLY
|
Cash from Investing Activities
-$7.2B
|
CAGR 3-Years
-47%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-13%
|
See Also
What is Aerie Pharmaceuticals Inc's Cash from Investing Activities?
Cash from Investing Activities
-18.3m
USD
Based on the financial report for Sep 30, 2022, Aerie Pharmaceuticals Inc's Cash from Investing Activities amounts to -18.3m USD.
What is Aerie Pharmaceuticals Inc's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 5Y
20%
Over the last year, the Cash from Investing Activities growth was 14%. The average annual Cash from Investing Activities growth rates for Aerie Pharmaceuticals Inc have been 44% over the past three years , 20% over the past five years .